Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

170.51
-0.6500-0.38%
Volume:2.54M
Turnover:432.01M
Market Cap:43.87B
PE:-11.99
High:170.63
Open:170.23
Low:169.20
Close:171.16
52wk High:176.60
52wk Low:133.73
Shares:257.32M
Float Shares:257.32M
Volume Ratio:1.39
T/O Rate:0.99%
Dividend:2.53
Dividend Rate:1.49%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.28
PE(LYR):-11.99

Loading ...

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live
·
Just now

Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...

Dow Jones
·
33 mins ago

Sunshine Lake Pharma Details Terms of New Healthcare-Focused Investment Fund

TIPRANKS
·
55 mins ago

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Definium Therapeutics (DFTX) and IDEAYA Biosciences (IDYA)

TIPRANKS
·
1 hour ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks

MT Newswires Live
·
2 hours ago

Sector Update: Healthcare

MT Newswires Live
·
2 hours ago

Sabra Healthcare REIT Price Target Raised to $23.00/Share from $21.00 by Barclays

Dow Jones
·
2 hours ago

States Namenda Tablets not Withdrawn for Safety or Effectiveness Reasons - Federal Register

THOMSON REUTERS
·
2 hours ago

FDA: Will not Begin Procedures to Withdraw Approval of Abbreviated New Drug Applications That Refer to Namenda Products - Federal Register

THOMSON REUTERS
·
2 hours ago

Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.

Dow Jones
·
2 hours ago

AbbVie to Present at Wells Fargo Healthcare Conference

Reuters
·
3 hours ago

Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference

GlobeNewswire
·
3 hours ago

Omega Healthcare is Maintained at Neutral by Mizuho

Dow Jones
·
3 hours ago

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
3 hours ago

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
3 hours ago

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
4 hours ago

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
4 hours ago

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
4 hours ago

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
4 hours ago

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
4 hours ago